Inhibition of Tyrosinase by Mercury Chloride: Spectroscopic and Docking Studies

Inorganic mercury compounds have been used in skin-lightening products since ancient times. Although a previous study demonstrated that mercury impeded the transfer of Cu to the apotyrosinase, the effect of mercury on tyrosinase is still unclear. In the present study, the mechanism of mercury chlori...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in pharmacology Vol. 11; p. 81
Main Authors Chen, Jianmin, Ye, Yaling, Ran, Mengnan, Li, Qinglian, Ruan, Zhipeng, Jin, Nan
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 06.03.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Inorganic mercury compounds have been used in skin-lightening products since ancient times. Although a previous study demonstrated that mercury impeded the transfer of Cu to the apotyrosinase, the effect of mercury on tyrosinase is still unclear. In the present study, the mechanism of mercury chloride (HgCl ) induced inactivation of tyrosinase was investigated for the first time. The IC values were 29.97 and 77.93 μmol/L for monophenolase and diphenolase, respectively. A kinetic analysis revealed that HgCl inhibited tyrosinase activity in an irreversible non-competitive manner. The strong intrinsic fluorescence quenching suggested that the formation of the HgCl -tyrosinase complex induced conformational changes of the enzyme, and HgCl had only one single binding site or a single class of binding site on tyrosinase. The molecular docking and further experiments demonstrated that HgCl bound to the amino residuals (His) in the catalytic center of tyrosinase. To our knowledge, these findings presented in this paper were the first evidence of the direct interactions between HgCl and tyrosinase, which provided a deep understanding of the inhibition mechanism of mercury on tyrosinase.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology
Edited by: Jamshed Iqbal, COMSATS University Islamabad, Pakistan
Reviewed by: Cláudia Sirlene Oliveira, Pelé Petit Prince Research Institute, Brazil; Mohamed A. Abdelgawad, Al Jouf University, Saudi Arabia
ISSN:1663-9812
1663-9812
DOI:10.3389/fphar.2020.00081